# Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures

> **NCT03451227** · NA · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 6 (actual)

## Conditions studied

- Tachyarrhythmia

## Interventions

- **DRUG:** Dexmedetomidine group
- **DRUG:** Remifentanil Group

## Key facts

- **NCT ID:** NCT03451227
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-01
- **Primary completion:** 2018-03-12
- **Final completion:** 2019-05-14
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Unable to recruit eligible participants
- **Last updated:** 2019-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451227, "Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03451227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*